FDA's Center for Biologics Evaluation and Research comments on the Report of the expert panel.

Ítems similars

• Regulatory Administrative Databases in FDA's Center for Biologics Evaluation and Research: Convergence Toward a Unified Database
  per: Smith, Jeffrey K.
  Publicat: (2012)
• FDA approves drugs even when experts on its advisory panels raise safety questions
  per: Landow, Laurence
  Publicat: (1999)
• Evidentiary Support in Public Comments to the FDA's Center for Tobacco Products
  per: Hemmerich, Natalie, et al.
  Publicat: (2017)
• COVID-19 emergency responders in FDA’s Center for Drug Evaluation and Research
  per: Gormley, Lieutenant Commander Andrea, et al.
  Publicat: (2020)
• South African experts comment on FDA approval of dabigatran inatrial fibrillation
  per: E, Klug, et al.
  Publicat: (2011)